Granulocyte-macrophage colony-stimulating factor as an arteriogenic factor in the treatment of ischaemic stroke

By Hossmann Konstantin-Alexander   Buschmann Ivo R  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1547-1556

Informa Healthcare

Access to resources Recommend Favorite

Pegfilgrastim: a granulocyte colony-stimulating factor with sustained duration of action

By Lyman Gary H  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 12, 2005-12 ,pp. : 1635-1646

Informa Healthcare

Access to resources Recommend Favorite

Combined use of GAP and AOX1 promoter to enhance the expression of human granulocyte-macrophage colony-stimulating factor in Pichia pastoris

By Wu J.M.   Lin J.C.   Chieng L.L.   Lee C.K.   Hsu T.A.  

Enzyme and Microbial Technology, Vol. 33, Iss. 4, 2003-09 ,pp. : 453-459

Elsevier

Access to resources Recommend Favorite

Contribution of glycosylated recombinant human granulocyte colony-stimulating factor (lenograstim) use in current cancer treatment: review of clinical data

By Gunzer Katharina   Clarisse Bénédicte   Lheureux Stéphanie   Delcambre Corinne   Joly Florence  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 4, 2010-04 ,pp. : 615-630

Informa Healthcare

Access to resources Recommend Favorite

Immunomodulatory effects of human recombinant granulocyte-macrophage colony-stimulating factor (rhuGM-CSF): evidence of antitumour activity

By Everly Jason J   Lonial Sagar  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 3, 2005-03 ,pp. : 293-311

Informa Healthcare

Access to resources Recommend Favorite